Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 6

Vaginal Microbiome May Influence Effectiveness of Pre-Exposure Prophylaxis
Better understanding of the vaginal microbiome may provide new insights into HIV acquisition.
WHO Launches New Guidance On Cryptococcal Meningitis
At CROI 2018, the World Health Organization released updated guidelines for cryptococcal disease in HIV-infected adults.
Dolutegravir Effective and Well-Tolerated in HIV/TB Co-Infected Adults
Study results revealed that dolutegravir appears to be effective and well-tolerated in HIV/tuberculosis (TB) co-infected adults also receiving rifampin-based TB therapy.
CDC Finds PrEP Not Reaching Americans Who Need It, Particularly African Americans
First detailed analysis by race and risk group finds that two-thirds of those who could benefit from PrEP are African American or Latino, but they account for the smallest percentage of prescriptions to date.
Bictegravir Single-Dose Combo Found to Be As Safe & Effective As DTG/ABC/3TC
Week 48 safety results show that switching to B/F/TAF was noninferior to remaining on DTG/ABC/3TC.
Trogarzo Approved by FDA for Multidrug-Resistant HIV
The US Food and Drug Administration (FDA) approved this new intravenously-administered HIV medication for patients who are suffering from multidrug-resistant HIV who have failed other antiretroviral therapies.
Bictegravir Combo Single-Dose Regimen Comparable to SBR in Select HIV-1 Positive Adults
Week 24 safety and efficacy data on women who switched from a baseline regimen (SBR) to B/F/TAF were presented at CROI 2018.
Exploring Factors That Contribute to Increased Risk of HIV Infection in Transgender Women
More research is needed but characterizing the biologic risk factors associated with HIV that are specific to transgender women may be key to informing more effective preventive strategies.